Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22WT1+antigen%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
/vufind/Search/Results?lookfor=%22WT1+antigen%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
Search /vufind/Search2/Results?lookfor=%22WT1+antigen%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
PubPharm (13)
1
Phase I/II clinical study of WT4869 peptide-based immunotherapy in patients with completely resected stage IA with vascular invasion, stage IB and stage II non-small cell lung cancer with WT1 antigen positive. : Phase I/II clinical study of WT4869 peptide-based immunotherapy in patients with completely resected stage IA with vascular invasion, stage IB and stage II non-small cell lung cancer with WT1 antigen positive. - Phase I/II clinical study of WT4869 peptide-based immunotherapy in patients with completely resected stage IA with vascular invasion, stage IB/II NSCLC with WT1 antigen positive.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
Clinical study of PepTivator(R) WT1-added autologous gamma/delta T cells therapy for cancer patients. : Clinical study of PepTivator(R) WT1-added autologous gamma/delta T cells therapy for cancer patients. - Clinical study of PepTivator(R) WT1-added autologous gamma/delta T cells therapy for cancer patients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
Phase I/II clinical study of WT4869 peptide-based immunotherapy in patients with completely resected stage IA with vascular invasion, stage IB and stage II non-small cell lung cancer with WT1 antigen positive. : Phase I/II clinical study of WT4869 peptide-based immunotherapy in patients with completely resected stage IA with vascular invasion, stage IB and stage II non-small cell lung cancer with WT1 antigen positive. - Phase I/II clinical study of WT4869 peptide-based immunotherapy in patients with completely resected stage IA with vascular invasion, stage IB/II NSCLC with WT1 antigen positive.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Clinical study of PepTivator(R) WT1-added autologous gamma/delta T cells therapy for cancer patients. : Clinical study of PepTivator(R) WT1-added autologous gamma/delta T cells therapy for cancer patients. - Clinical study of PepTivator(R) WT1-added autologous gamma/delta T cells therapy for cancer patients.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
Cloning and expansion of antigen-specific T cells using iPS cell technology : development of "off-the-shelf" T cells for the use in allogeneic transfusion settings
enthalten in:
International journal of hematology
| 2018
von
Kawamoto, H.
|
Masuda, K.
|
Nagano, S.
| +1
Wird geladen...
6
Cloning and expansion of antigen-specific T cells using iPS cell technology: development of “off-the-shelf” T cells for the use in allogeneic transfusion settings
enthalten in:
International journal of hematology
| 2018
von
Kawamoto, H.
|
Masuda, K.
|
Nagano, S.
| +1
Wird geladen...
7
Cloning and expansion of antigen-specific T cells using iPS cell technology: development of “off-the-shelf” T cells for the use in allogeneic transfusion settings
enthalten in:
International journal of hematology
| 2018
von
Kawamoto, H.
|
Masuda, K.
|
Nagano, S.
| +1
Wird geladen...
8
Cloning and expansion of antigen-specific T cells using iPS cell technology: development of “off-the-shelf” T cells for the use in allogeneic transfusion settings
enthalten in:
International journal of hematology
| 2018
von
Kawamoto, H.
|
Masuda, K.
|
Nagano, S.
| +1
Wird geladen...
9
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer : a randomized Phase I study
enthalten in:
Breast cancer research and treatment
| 2017
von
Higgins, M.
|
Curigliano, G.
|
Dieras, V.
| +14
Wird geladen...
10
Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study
enthalten in:
Breast cancer research and treatment
| 2017
von
Higgins, M.
|
Curigliano, G.
|
Dieras, V.
| +14
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
13
Aufsätze
11
E-Artikel
11
E-Ressourcen
2
Gedruckte Aufsätze
Zeitschriftentitel
4
Breast cancer research and treatment
4
International journal of hematology
4
WHO International Clinical Trials Registry Plat...
1
Anticancer research
Thema
8
WT1 antigen
5
Adoptive immunotherapy
4
610
4
Breast cancer
4
CD8αβ T cells
4
Immunogenicity
4
Immunotherapy
4
Neoadjuvant therapy
4
Recruitment Status: Complete: follow-up complete
4
Safety
4
Study Type: Interventional
4
iPS cells
3
Journal Article
3
WT1 Proteins
2
Antigens, Neoplasm
2
Medical Condition: Completely resected NSCLC, s...
2
Medical Condition: Patients who have malignant ...
2
Phase: Phase 1/Phase 2
2
Review
1
Antibodies
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4
2020-
9
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
13
Englisch
Haven't found what you're looking for?
Wird geladen...